| Value | ₹250.0 Cr |
|---|
BSE filing, NSE: SRM. Summary written from the filing by ALFA Finder's alert engine.
SRM Contractors Ltd: key numbers
- Share price
- ₹406.40
- Market cap
- ₹932.5 Cr
- Revenue (annual)
- ₹1,026 Cr
- Net profit (annual)
- ₹111.0 Cr
- P/E (TTM)
- 7.9×Sector 32.2×
- Promoter holding
- 72.59%+0.00% QoQ
- FII holding
- 0.06%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from SRM Contractors Ltd
All →SRM Contractors Bags ₹138.4 Cr Order from MORTH
SRM Contractors bagged a Rs.138.37 Crore contract from MORTH for landslide treatment on NH-09 in Uttarakhand. Execution is 18 months on EPC mode.
- Value
- ₹138.4 Cr
- From
- MORTH (Ministry of Road, Transport and Highways)
- Execution
- 18 months
SRM Contractors Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
SRM Contractors Management Change
SRM Contractors Limited announced the appointment of a new statutory auditor and a change in designation for director Ashley Mehta.
SRM Contractors Annual General Meeting
SRM Contractors Limited held its 18th Annual General Meeting on September 30, 2026, through video conferencing to transact the business listed in the AGM notice.
SRM Contractors Merger & Restructuring Worth ₹0.26 Cr
SRM Contractors Ltd converted its Abu Dhabi branch into a wholly-owned subsidiary, SRM Contractors LLC, with an initial capital investment equivalent to ₹0.26 Crore.
- Value
- ₹0.26 Cr
SRM Contractors Other Announcement
SRM Contractors Ltd has submitted its quarterly shareholding pattern for the period ending March 31, 2026. This is a routine regulatory compliance filing.
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr